Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact

Capitalizing on available data, we used a decision model to estimate the clinical and economic outcomes associated with early initiation of treatment with neuraminidase inhibitors in all patients with influenza-like illnesses ( ILI ) (systematic strategy) vs. only those at high risk of complications...

Descripción completa

Detalles Bibliográficos
Autores principales: Deuffic-Burban, Sylvie, Lenne, Xavier, Dervaux, Benoit, Julien Poissy, Lemaire, Xavier, Sloan, Caroline, Carrat, Fabrice, Desenclos, Jean-Claude, Delfraissy, Jean-Francois, Yazdanpanah, Yazdan
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Influenza
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768144/
https://www.ncbi.nlm.nih.gov/pubmed/20029659
http://dx.doi.org/10.1371/currents.RRN1121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768144/
https://www.ncbi.nlm.nih.gov/pubmed/20029659
http://dx.doi.org/10.1371/currents.RRN1121

Ejemplares similares